InChI=1S/C27H35N6O8P/c1- 4- 18(5- 2) 13- 38- 26(36) 17(3) 32- 42(37,41- 19- 9- 7- 6- 8- 10- 19) 39- 14- 21- 23(34) 24(35) 27(15- 28,40- 21) 22- 12- 11- 20- 25(29) 30- 16- 31- 33(20) 22/h6- 12,16- 18,21,23- 24,34- 35H,4- 5,13- 14H2,1- 3H3,(H,32,37) (H2,29,30,31) /t17- ,21+,23+,24+,27- ,42- /m0/s1 |
RWWYLEGWBNMMLJ-YSOARWBDSA-N |
[C@] 1(O[C@@H] ([C@H] ([C@H] 1O) O) CO[P@@] (N[C@H] (C(OCC(CC) CC) =O) C) (OC=2C=CC=CC2) =O) (C#N) C=3N4N=CN=C(C4=CC3) N |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
anticoronaviral agent
Any antiviral agent which inhibits the activity of coronaviruses.
antiviral drug
A substance used in the prophylaxis or therapy of virus diseases.
|
|
antiviral drug
A substance used in the prophylaxis or therapy of virus diseases.
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
|
|
View more via ChEBI Ontology
2- ethylbutyl N- [(S)- {[(2R,3S,4R,5R)- 5- (4- aminopyrrolo[2,1- f][1,2,4]triazin- 7- yl)- 5- cyano- 3,4- dihydroxytetrahydrofuran- 2- yl]methoxy}(phenoxy)phosphoryl]- L- alaninate
|
remdésivir
|
WHO MedNet
|
remdesivir
|
WHO MedNet
|
remdesivir
|
WHO MedNet
|
remdesivirum
|
WHO MedNet
|
(2S)- 2- {(2R,3S,4R,5R)- [5- (4- Aminopyrrolo[2,1- f][1,2,4]triazin- 7- yl)- 5- cyano- 3,4- dihydroxy- tetrahydro- furan- 2- ylmethoxy]phenoxy- (S)- phosphorylamino}propionic acid 2- ethyl- butyl ester
|
ChEBI
|
2- ethylbutyl (2S)- 2- {[(S)- {[(2R,3S,4R,5R)- 5- (4- aminopyrrolo[2,1- f][1,2,4]triazin- 7- yl)- 5- cyano- 3,4- dihydroxytetrahydrofuran- 2- yl]methoxy}(phenoxy)phosphoryl]amino}propanoate
|
ChEBI
|
GS 5734
|
DrugBank
|
GS-5734
|
ChemIDplus
|
GS5734
|
ChEBI
|
1809249-37-3
|
CAS Registry Number
|
ChemIDplus
|
|